Assessment of the lateral diffusion and penetration of topically applied drugs in humans using a novel concentric tape stripping design

Pharmaceutical Research

Volumn 29, Issue 8, 2012, Pages 2035-2046

  Gee, C M ^a   Nicolazzo, J A ^a   Watkinson, A C ^b   Finnin, B C ^a  

^a MONASH UNIVERSITY   (Australia)

^b Storith Consulting   (United Kingdom)

Author keywords

Lateral diffusion; Penetration; Percutaneous absorption; Stratum corneum; Tape stripping

Indexed keywords

ALCOHOL; CAFFEINE; HYDROCORTISONE; IBUPROFEN; PROTEIN;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONCENTRIC TAPE STRIPPING; DRUG ABSORPTION; DRUG DETERMINATION; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG TISSUE LEVEL; FEMALE; FOREARM; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR WEIGHT; NORMAL HUMAN; PHARMACOLOGICAL PROCEDURES; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STRATUM CORNEUM;

ADHESIVES; ADMINISTRATION, TOPICAL; ADULT; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG DELIVERY SYSTEMS; EPIDERMIS; FEMALE; HUMANS; HYDROCORTISONE; IBUPROFEN; MALE; SKIN ABSORPTION; YOUNG ADULT;

EID: 84864435814     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-012-0731-7     Document Type: Article

References (42)

1. Hadgraft J, Whitefield M, Rosher PH. Skin penetration of topical formulations of ibuprofen 5 %: an in vitro comparative study. Skin Pharmacol Appl. 2003;16(3):137-42.
2. Surber C, Davis AF. Bioavailability and bioequivalence of dermatogolgical formulations. In: Walters KA, editor. Drugs and the pharmaceutical sciences-dermatological and transdermal formulations: Informa Healthcare; 2002. pp. 401-98.
3. Jacobi U, Weigmann HJ, Baumann M, Reiche AI, Sterry W, Lademann J. Lateral spreading of topically applied uv filter substances investigated by tape stripping. Skin Pharmacol Physiol. 2004;17(1):17-22.
4. Schicksnus G, Muller-Goymann CC. Lateral diffusion of ibuprofen in human skin during permeation studies. Skin Pharmacol Physiol. 2004;17(2):84-90.
5. Johnson ME, Berk DA, Blankschtein D, Golan DE, Jain RK, Langer RS. Lateral diffusion of small compounds in human stratum corneum and model lipid bilayer systems. Biophys J. 1996;71 (5):2656-68.
6. Johnson ME, Blankschtein D, Langer R. Evaluation of solute permeation through the stratum corneum: Lateral bilayer diffusion as the primary transport mechanism. J Pharm Sci. 1997;86 (10):1162-72.
7. FDA. Topical testosterone gel products (marketed as androgel 1 % and testim 1 %): Secondary exposure of children to topical testosterone products. FDA Drug Safety Newsletter. 2009.
8. Kasting GB, Francis WR, Roberts GE. Skin penetration enhancement of triprolidine base by propylene-glycol. J Pharm Sci. 1993;82(5):551-2.
9. Leo A, Hansch C, Elkins D. Partition coefficients and their uses. Chem Rev. 1971;71(6):525-616.
10. Yano T, Nakagawa A, Tsuji M, Noda K. Skin permeability of various nonsteroidal antiinflammatory drugs in man. Life Sci. 1986;39(12):1043-50.
11. El-Kattan AF, Asbill CS, Kim N, Michniak BB. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int J Pharm. 2001;215(1-2):229-40.
12. Rhee YS, Chang SY, Park CW, Chi SC, Park ES. Optimization of ibuprofen gel formulations using experimental design technique for enhanced transdermal penetration. Int J Pharm. 2008;364 (1):14-20.
13. Treffel P, Gabard B. Ibuprofen epidermal levels after topical application in vitro: effect of formulation, application time, dose variation and occlusion. Br J Dermatol. 1993;129(3):286-91.
14. Iervolino M, Raghavan SL, Hadgraft J. Membrane penetration enhancement of ibuprofen using supersaturation. Int J Pharm. 2000;198(2):229-38.
15. Johnson ME, Blankschtein D, Langer R. Permeation of steroids through human skin. J Pharm Sci. 1995;84(9):1144-6.
16. Dias M, Farinha A, Faustino E, Hadgraft J, Pais J, Toscano C. Topical delivery of caffeine from some commercial formulations. Int J Pharm. 1999;182(1):41-7.
17. Herkenne C, Naik A, Kalia YN, Hadgraft J, Guy RH. Ibuprofen transport into and through skin from topical formulations: in vitro-in vivo comparison. J Invest Dermatol. 2007;127(1):135-42.
18. Almeida PFF, Vaz WLC, Thompson TE. Lateral diffusion in the liquid-phases of dimyristoylphosphatidylcholine cholesterol lipid bilayers-a free-volume analysis. Biochemistry. 1992;31(29):6739-47.
19. Lieb WR, Stein WD. Non-stokesian nature of transverse diffusion within human red-cell membranes. J Membrane Biol. 1986;92 (2):111-9.
20. Olson B, Markwell J. Assays for determination of protein concentration. Current protocols in protein science: Forward; 2007. p. 3.4.1-3.4.29.
21. Eltayar N, Tsai RS, Testa B, Carrupt PA, Hansch C, Leo A. Percutaneous penetration of drugs-a quantitative structure permeability relationship study. J Pharm Sci. 1991;80(8):744-9.
22. Naik A,Kalia YN, Guy RH. Transdermal drug delivery: overcoming the skin's barrier function. Pharm Sci Techno To. 2000;3(9):318-26.
23. Malkinson FD, Ferguson EH. Percutaneous absorption of hydrocortisone-4-c-14 in 2 human subjects. J Invest Dermatol. 1955;25(5):281-3.
24. Hadgraft J. Epidermal reservoir-theoretical approach. Int J Pharm. 1979;2(5-6):265-74.
25. Vickers CF. Existence of reservoir in the stratum corneum. Experimental proof. Arch Dermatol. 1963;88:20-3.
26. Gloor M, Willebrandt U, Thomer G, Kupferschmid W. Water content of the horny layer and skin surface lipids. Arch Dermatol Res. 1980;268(2):221-3.
27. Idson B. Percutaneous absorption. J Pharm Sci. 1975;64(6):901-24.
28. Phillips CA, Michniak BB. Transdermal delivery of drugs with differing lipophilicities using azone analogs as dermal penetration enhancers. J Pharm Sci. 1995;84(12):1427-33.
29. Lee CK, Uchida T, Kitagawa K, Yagi A, Kim NS, Goto S. Skin permeability of various drugs with different lipophilicity. J Pharm Sci. 1994;83(4):562-5.
30. Simonsen L, PetersenMB, Benfeldt E, Serup J.Development of an in vivo animalmodel for skin penetration in hairless rats assessed bymass balance. Skin Pharmacol Appl Skin Physiol. 2002;15(6):414-24.
31. Rhodes LE, Diffey BL. Fluorescence spectroscopy: a rapid, noninvasive method for measurement of skin surface thickness of topical agents. Br J Dermatol. 1997;136(1):12-7.
32. Johnson R, Nusbaum BP, Horwitz SN, Frost P. Transfer of topically applied tetracycline in various vehicles. Arch Dermatol. 1983;119(8):660-3.
33. Bo Nielsen J, Ahm Sorensen J, Nielsen F. The usual suspectsinfluence of physicochemical properties on lag time, skin deposition, and percutaneous penetration of nine model compounds. J Toxicol Environ Health A. 2009;72(5):315-23.
34. Akomeah FK, Martin GP, Brown MB. Variability in human skin permeability in vitro: comparing penetrants with different physicochemical properties. J Pharm Sci. 2007;96(4):824-34.
35. Potard G, Laugel C, Baillet A, Schaefer H, Marty JP. Quantitative hplc analysis of sunscreens and caffeine during in vitro percutaneous penetration studies. Int J Pharm. 1999;189(2):249-60.
36. Nicoli S, Amoretti V, Colombo P, Santi P. Bioadhesive transdermal film containing caffeine. Skin Pharmacol Physiol. 2004;17(3): 119-23.
37. Mirejovsky D, Takruri H. Dermal penetration enhancement profile of hexamethylenelauramide and its homologues: in vitro versus in vivo behavior of enhancers in the penetration of hydrocortisone. J Pharm Sci. 1986;75(11):1089-93.
38. Godwin DA, Michniak BB. Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Dev Ind Pharm. 1999;25(8):905-15.
39. Refai H, Muller-Goymann CC. The influence of dilution of topical semisolid preparations on hydrocortisone permeation through excised human stratum corneum. Eur J Pharm Biopharm. 2002;54 (2):143-50.
40. Britz MB, Maibach HI, Anjo DM. Human percutaneous penetration of hydrocortisone: the vulva. Arch Dermatol Res. 1980;267 (3):313-6.
41. Feldmann RJ, Maibach HI. Penetration of 14c hydrocortisone through normal skin: the effect of stripping and occlusion. Arch Dermatol. 1965;91:661-6.
42. VanderMolen RG, Spies F, Vant Noordende JM, Boelsma E, Mommaas AM, Koerten HK. Tape stripping of human stratum corneum yields cell layers that originate from various depths because of furrows in the skin. Arch Dermatol Res. 1997;289(9):514-8.